InterMune shares rise after FDA panel drug votes (AP)
March 10, 2010
Shares of InterMune Inc. rose at a blistering pace Wednesday, a day after a federal advisory panel voted in favor of approval for its experimental lung disease treatment.
Klik hier voor het volledige verhaal
Annoncer:
Andre Nyheder
- UPDATE – HudBay operating results rise; NYSE listing planned (at Reuters)
- [$$] Old Favorites Day (at TheStreet.com)
- China passeert Japan als tweede economie ter wereld
- GM investeert 500 miljoen dollar in Mexico
- Zuid-Europa: hete soep
- Crush of mud finally plugs BP’s well in the Gulf
Kommentarer
